Literature DB >> 149663

Immunity in Down's syndrome.

G R Burgio, A G Ugazio.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 149663     DOI: 10.1007/bf00493546

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  11 in total

1.  T system immune-deficiency in Down's syndrome.

Authors:  S Levin; E Nir; B M Mogilner
Journal:  Pediatrics       Date:  1975-07       Impact factor: 7.124

2.  [The Down's syndrome as immune deficiency model. Observations and hypothesis].

Authors:  G R Burgio; A G Ugazio
Journal:  Helv Paediatr Acta       Date:  1978-04

3.  Anicteric hepatitis associated with Australia antigen. Occurrence in patients with Down's syndrome.

Authors:  A I Sutnick; W T London; B J Gerstley; M M Cronlund; B S Blumberg
Journal:  JAMA       Date:  1968-09-02       Impact factor: 56.272

4.  Peripheral blood 'rosette forming lymphocytes' in Down's syndrome.

Authors:  G R Burgio; A G Ugazio; L Nespoli
Journal:  Experientia       Date:  1974-07-15

5.  Gm antigenic titres in adults with Down's syndrome (mongolism), non-mongoloid mental defectives and healthy blood donors.

Authors:  H Thom; E McKay
Journal:  Clin Exp Immunol       Date:  1972-12       Impact factor: 4.330

6.  T-lymphocyte deficiency in Down syndrome.

Authors:  A G Ugazio; R Maccario; M Duse; G R Burgio
Journal:  Lancet       Date:  1977-05-14       Impact factor: 79.321

7.  Letter: Ageing, T lymphocytes, and Down's syndrome.

Authors:  G R Burgio; L Nespoli
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

8.  DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndrome.

Authors:  S S Agarwal; B S Blumberg; B J Gerstley; W T London; A I Sutnick; L A Loeb
Journal:  J Clin Invest       Date:  1970-01       Impact factor: 14.808

9.  Immunodeficiency in Down's syndrome: relationship between presence of human thyroglobulin antibodies and HBsAg carrier status.

Authors:  A G Ugazio; S D Jayakar; A F Marcioni; M Duse; V Monafo; F Pasquali; G R Burgio
Journal:  Eur J Pediatr       Date:  1977-10-12       Impact factor: 3.183

10.  [Humoral immunity and blastic transformation of lymphocytes in trisomy 21].

Authors:  R Bernard; S Sitrk; D Bernard; J F Mattei
Journal:  Arch Fr Pediatr       Date:  1976-01
View more
  8 in total

1.  Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.

Authors:  S Raziuddin; M E Elawad
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

2.  Monoclonal antibody defined T cell subsets and autologous mixed lymphocyte reaction in Down's syndrome.

Authors:  S Gupta; S M Fikrig; E Mariano; Q Quazi
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

3.  Graves' disease and Down's syndrome.

Authors:  A J McCulloch; F Clark; N R Steele
Journal:  J Med Genet       Date:  1983-04       Impact factor: 6.318

4.  Autoimmune chronic active hepatitis in Down's syndrome.

Authors:  A J McCulloch; P G Ince; P Kendall-Taylor
Journal:  J Med Genet       Date:  1982-06       Impact factor: 6.318

5.  Community study of hypothyroidism in Down's syndrome.

Authors:  E de H Lobo; M Khan; J Tew
Journal:  Br Med J       Date:  1980-05-24

6.  Natural course of subclinical hypothyroidism in Down's syndrome: prospective study results and therapeutic considerations.

Authors:  D Rubello; G B Pozzan; D Casara; M E Girelli; S Boccato; F Rigon; C Baccichetti; M Piccolo; C Betterle; B Busnardo
Journal:  J Endocrinol Invest       Date:  1995-01       Impact factor: 4.256

Review 7.  Down syndrome and coeliac disease: five new cases with a review of the literature.

Authors:  M I Hilhorst; M Brink; E A Wauters; R H Houwen
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183

Review 8.  Metabolism and possible health effects of aluminum.

Authors:  P O Ganrot
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.